FR2825921B1 - Inhibiteur de no-synthase et utilisations - Google Patents

Inhibiteur de no-synthase et utilisations

Info

Publication number
FR2825921B1
FR2825921B1 FR0107878A FR0107878A FR2825921B1 FR 2825921 B1 FR2825921 B1 FR 2825921B1 FR 0107878 A FR0107878 A FR 0107878A FR 0107878 A FR0107878 A FR 0107878A FR 2825921 B1 FR2825921 B1 FR 2825921B1
Authority
FR
France
Prior art keywords
synthase inhibitor
synthase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0107878A
Other languages
English (en)
Other versions
FR2825921A1 (fr
Inventor
Grierson Marie Madeleine Cals
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0107878A priority Critical patent/FR2825921B1/fr
Priority to JP2003504933A priority patent/JP2004534069A/ja
Priority to EP02758511A priority patent/EP1401393A2/fr
Priority to PCT/FR2002/002064 priority patent/WO2002102344A2/fr
Publication of FR2825921A1 publication Critical patent/FR2825921A1/fr
Priority to US10/733,387 priority patent/US20040152735A1/en
Application granted granted Critical
Publication of FR2825921B1 publication Critical patent/FR2825921B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR0107878A 2001-06-15 2001-06-15 Inhibiteur de no-synthase et utilisations Expired - Fee Related FR2825921B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0107878A FR2825921B1 (fr) 2001-06-15 2001-06-15 Inhibiteur de no-synthase et utilisations
JP2003504933A JP2004534069A (ja) 2001-06-15 2002-06-14 Ｎｏ−シンターゼインヒビターとその用途
EP02758511A EP1401393A2 (fr) 2001-06-15 2002-06-14 Inhibiteur de no-synthase et utilisations
PCT/FR2002/002064 WO2002102344A2 (fr) 2001-06-15 2002-06-14 Inhibiteur de no-synthase et utilisations
US10/733,387 US20040152735A1 (en) 2001-06-15 2003-12-12 NO-synthase inhibitors comprising N,N'-bis(2-pyridyl)methyl-N,N'-bis(3,4,5-trimethoxybenzyl) ethylenediamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0107878A FR2825921B1 (fr) 2001-06-15 2001-06-15 Inhibiteur de no-synthase et utilisations

Publications (2)

Publication Number Publication Date
FR2825921A1 FR2825921A1 (fr) 2002-12-20
FR2825921B1 true FR2825921B1 (fr) 2005-02-11

Family

ID=8864373

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0107878A Expired - Fee Related FR2825921B1 (fr) 2001-06-15 2001-06-15 Inhibiteur de no-synthase et utilisations

Country Status (5)

Country Link
US (1) US20040152735A1 (fr)
EP (1) EP1401393A2 (fr)
JP (1) JP2004534069A (fr)
FR (1) FR2825921B1 (fr)
WO (1) WO2002102344A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2456035A1 (fr) * 2003-02-03 2004-08-03 L'oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
FR2850578B1 (fr) * 2003-02-03 2006-07-28 Oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959551A (en) * 1989-02-27 1990-09-25 Gte Products Corporation Cosmetic tanning lamp and system having adjustable UVB proportion
US5703095A (en) * 1992-11-13 1997-12-30 L'oreal Use of N-arylmethylene, ethylenediaminetriacetates, N-arymethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress
AU5317296A (en) * 1995-03-24 1996-10-16 Francis V. Defeudis Methods for treating conditions associated with excess nitri c oxide
FR2737205B1 (fr) * 1995-07-26 1997-09-12 Oreal Nouveaux derives de n,n'-di(aralkyl) n,n'-di(2-azaaralkyl) alkylene diamine et leur utilisation dans des compositions pharmaceutiques et cosmetiques
FR2740339B1 (fr) * 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
DE19711565A1 (de) * 1997-02-21 1998-08-27 Beiersdorf Ag Zubereitungen für die Behandlung von Rosacea
FR2786694B1 (fr) * 1998-12-03 2002-09-27 Serobiologiques Lab Sa Utilisation d'extraits de plantes notamment a action anti-radicalaire et composition cosmetique ou dermopharmaceutique comportant de tels extraits
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives

Also Published As

Publication number Publication date
WO2002102344A2 (fr) 2002-12-27
WO2002102344A3 (fr) 2003-03-20
JP2004534069A (ja) 2004-11-11
EP1401393A2 (fr) 2004-03-31
US20040152735A1 (en) 2004-08-05
FR2825921A1 (fr) 2002-12-20

Similar Documents

Publication Publication Date Title
CY2015028I1 (el) Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
ATE286049T1 (de) Pyridazinonaldose reductase inhibitoren
PT1370553E (pt) Inibidores de rhoquinase
FI20011140A0 (fi) Älytarra ja älytarraraina
NO20043067L (no) Dynamisk tilstedevaerelsesadministrasjon
ID30187A (id) Dongkrak jenis pantagraf
PT1272488E (pt) Inibidores de pde4 etanos tri-aril-substituidos
FR2825920B1 (fr) Desferal comme inhibiteur de no-synthase et utilisations
DE60207331D1 (de) Befestigungselement
FR2808189B1 (fr) Lipochroman-6 comme inhibiteur de no-synthase et utilisations
DE60007360D1 (de) Amorphe modifikation von torasemid
ATE299873T1 (de) Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
FR2825921B1 (fr) Inhibiteur de no-synthase et utilisations
DE60139773D1 (de) Ionisierungsstab
FR2825923B1 (fr) Inhibiteur de no-synthase et utilisations
DE60110606D1 (de) 16alpha-methyl oder ethyl substituierte oestrogene
ATE476164T1 (de) Saugfähiger artikel
ATE354561T1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen
DE60219418D1 (de) Silanylphenole und -naphthole
DE60140770D1 (de) Fixier- und zwischenübertragungsrollen
FR2825922B1 (fr) 2-hexadecanoate d'ascorbyle comme inhibiteur de no-synthase et utilisations
ITMI20011210A0 (it) Corticosteroidi-21-glicolati e 21-acilglicolati
SE0101785D0 (sv) Föremål av stål
FI4889U1 (fi) Kiinnitin
FI5019U1 (fi) Kiinnityslaite

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080229